论文部分内容阅读
小细胞肺癌(SCLC)在确诊时约有12 %～15 %的患者已存在脑转移,随病程延长脑转移率增加,2年以上生存者则可高达80 %[1 ] 。作者将快速静滴甘露醇可逆性开放血脑屏障应用于SCLC的临床治疗,现报告如下。1 资料与方法1·1 一般资料 本组81例病人均经病理证实为广泛期SCLC ,其中:
Small cell lung cancer (SCLC) at the time of diagnosis, about 12% to 15% of patients already have brain metastases, with prolonged brain metastases increased, more than 2 years of survival can be as high as 80% [1]. The authors will rapidly intravenous infusion of mannitol reversible open blood-brain barrier for the clinical treatment of SCLC, are as follows. 1 Materials and Methods 1.1 General Information 81 patients in this group were pathologically confirmed as extensive stage SCLC, of which: